OGN logo

OGNOrganon & Co.

$13.46
$0.005
(0.04%)
Today
Updated: 11:48 AM EDT
EarningsAug 4
Mkt Cap$3.53B
Vol314,593.00
66

Bullish Sentiment

How do you feel about OGN?

News
all
press releases
Organon Wins FDA Nod to Expand TOFIDENCE Use in Severe CRS & COVID-19
OGN's TOFIDENCE gains FDA approval for life-threatening CRS and certain hospitalized COVID-19 patients, broadening its critical-care role.
Zacks
News Placeholder
More News
News Placeholder
Organon Secures US Food and Drug Administration Approval Expanding Indications for TOFIDENCE (tocilizumab-bavi) in Cytokine Release Syndrome (CRS) and Pediatric COVID-19
Organon (NYSE: OGN) today announced the US Food and Drug Administration (FDA) approval of the supplemental Biologics License Application (sBLA) for TOFIDENCE (tocilizumab-bavi) injection, for intravenous use, a biosimilar to ACTEMRA (tocilizumab). The approval expands TOFIDENCE indications to...
Business Wire
News Placeholder
Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It
Organon (OGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Zacks
News Placeholder
Gilead, Merck, Eli Lilly Lead $106B Biopharma Takeover Wave In 2026
Biopharma M&A has surged to $106 billion across 201 deals through early June 2026, putting the sector on track for its strongest full-year total since the 2019 pre-pandemic peak, CNBC reported.
Stocktwits
News Placeholder
Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know
Zacks.com users have recently been watching Organon (OGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Zacks
News Placeholder
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know
Organon (OGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Zacks
News Placeholder
Organon to Present New Research on Access and Value at ISPOR 2026
Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, will present data across womens health, biosimilars...
Business Wire
News Placeholder
Are XOMA, OGN, VRE Obtaining Fair Deals for their Shareholders?
Are XOMA, OGN, VRE Obtaining Fair Deals for their Shareholders? Are XOMA, OGN, VRE Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, May 14, 2026 Insiders may stand to receive...
PR Newswire
News Placeholder
Organon & Co. (NYSE:OGN) Reaches New 1-Year High - Time to Buy?
Organon & Co. (NYSE:OGN) Sets New 1-Year High - What's Next...
MarketBeat
News Placeholder
SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--HLX, OGN, XOMA, and RMAX
SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--HLX, OGN, XOMA, and RMAX SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--HLX, OGN, XOMA, and RMAX PR Newswire NEW YORK, May 6, 2026 NEW YORK, May 6, 2026 /PRNewswire/ -- Class Action AttorneyJuan...
PR Newswire
<
1
2
...
>

Advertisement|Remove ads.